Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 18/20 | 0.52 |
| ▸ | NPY1R | P25929 | 11/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.52 |
| ▸ | NPY2R | P49146 | 7/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13724544 | 1.00 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL16566054 | 0.94 | NPY4R (0.45) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1394660 | 0.94 | NPY4R (0.45) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1394656 | 0.94 | NPY4R (0.45) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL16565958 | 0.94 | NPY4R (0.45) | NPY4RNPY1RNPY5RNPY2R | |
| Hydrochloric Acid SCHEMBL11142131 | 0.93 | NPY4R (0.44) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL17867003 | 0.90 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL17867009 | 0.90 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2R | |
| Leupeptin SCHEMBL13933715 | 0.90 | NPY4R (0.46) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| Leupeptin SCHEMBL583830 | 0.90 | NPY4R (0.46) | NPY4RNPY1RNPY5RNPY2RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2874997-A2 | NOVEL SIGMA RECEPTOR LIGANDS AND METHODS OF MODULATING CELLULAR PROTEIN HOMEOSTASIS USING SAME | Drexel University (US) | 2015-05-27 | — | — | EP | claimed |
| WO-2014015157-A2 | NOVEL SIGMA RECEPTOR LIGANDS AND METHODS OF MODULATING CELLULAR PROTEIN HOMEOSTASIS USING SAME | PHILADELPHIA HEALTH & EDUCATION CORPORATION (US) | 2014-01-23 | — | — | WO | claimed |
| EP-1638579-A2 | COMPOSITIONS AND METHODS FOR USE OF A PROTEASE INHIBITOR AND ADENOSINE FOR PREVENTING ORGAN ISCHEMIA AND REPERFUSION INJURY | EMORY UNIVERSITY (US) | 2006-03-29 | — | — | EP | claimed |
| WO-2005003150-A2 | COMPOSITIONS AND METHODS FOR USE OF A PROTEASE INHIBITOR AND ADENOSINE FOR PREVENTING ORGAN ISCHEMIA AND REPERFUSION INJURY | EMORY UNIVERSITY (US) | 2005-01-13 | — | — | WO | claimed |
| WO-2023067380-A1 | GENETIC SYSTEM FOR THE BIOSYNTHESIS OF LEUPEPTIN AND USE THEREOF IN HETEROLOGOUS PRODUCTION SYSTEMS | CENTRO DE INVESTIGACIÓN Y DE ESTUDIOS AVANZADOS DEL INSTITUTO POLITÉCNICO NACIONAL (MX) | 2023-04-27 | — | — | WO | disclosed |
| EP-4142589-A1 | VACUUM GENERATION DEVICES AND METHODS | YourBio Health, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| WO-2021222805-A1 | VACUUM GENERATION DEVICES AND METHODS | SEVENTH SENSE BIOSYSTEMS, INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| WO-2017106312-A1 | METHODS OF MODULATING LEVELS OF IL-6 AND PD-L1 | DREXEL UNIVERSITY (US) | 2017-06-22 | — | — | WO | disclosed |
| EP-2701601-A1 | DEVICES AND METHODS FOR COLLECTION AND/OR MANIPULATION OF BLOOD SPOTS OR OTHER BODILY FLUIDS | Seventh Sense Biosystems, Inc. (US) | 2014-03-05 | — | — | EP | disclosed |
| WO-2012149134-A1 | DEVICES AND METHODS FOR COLLECTION AND/OR MANIPULATION OF BLOOD SPOTS OR OTHER BODILY FLUIDS | SEVENTH SENSE BIOSYSTEMS, INC. (US) | 2012-11-01 | — | — | WO | disclosed |
| EP-2501401-A1 | METHOD FOR PURIFYING FACTOR B | Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme (FR) | 2012-09-26 | — | — | EP | disclosed |
| WO-2011058285-A1 | METHOD FOR MANUFACTURING A FACTOR H PREPARATION | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES (FR) | 2011-05-19 | — | — | WO | disclosed |
| WO-2005058837-A1 | BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2005-06-30 | — | — | WO | disclosed |
| WO-2004056369-A1 | BENZO ‘ D!AZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | GLAXO GROUP LIMITED (GB) | 2004-07-08 | — | — | WO | disclosed |
| US-5876747-A | CARNITINE, AMINOCARNITINE AND CYSTEIC ACID AS CARRIERS | CEPTOR CORPORATION | 1999-03-02 | — | — | US | disclosed |
| EP-0279887-B1 | Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder | STRACHER ALFRED (US) | 1995-02-01 | — | — | EP | disclosed |
| US-5008288-A | Skeletal & heat muscle disorders | CEPTOR CORPORATION | 1991-04-16 | — | — | US | disclosed |
| US-4866040-A | DRUG COVALENTLY BONDED TO AMINOCARNITINE FOR DELIVERY TO SPECI FIC SITES | CEPTOR CORPORATION | 1989-09-12 | — | — | US | disclosed |
| EP-0279887-A2 | Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder | Stracher, Alfred (US) | 1988-08-31 | — | — | EP | disclosed |
| US-4742081-A | Carnitine coupled pharmaceutical agents | CEPTOR CORPORATION | 1988-05-03 | — | — | US | disclosed |